These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20467617)

  • 1. The efficacy of enamel matrix derivative (Emdogain) for the treatment of deep infrabony periodontal defects: a placebo-controlled randomised clinical trial.
    Grusovin MG; Esposito M
    Eur J Oral Implantol; 2009; 2(1):43-54. PubMed ID: 20467617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.
    Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
    Eur J Oral Implantol; 2009; 2(4):247-66. PubMed ID: 20467602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of a resorbable bone substitute with a resorbable membrane in the treatment of periodontal infrabony defect - A multicenter randomised controlled trial.
    Esposito M; Grusovin MG; Lambert F; Matos S; Pietruska M; Rossi R; Salhi L; Buti J
    Eur J Oral Implantol; 2015; 8(3):233-44. PubMed ID: 26355168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects.
    Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD003875. PubMed ID: 19821315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.
    Esposito M; Grusovin MG; Coulthard P; Worthington HV
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003875. PubMed ID: 16235343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.
    Esposito M; Coulthard P; Worthington HV
    Cochrane Database Syst Rev; 2003; (2):CD003875. PubMed ID: 12804493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study.
    Francetti L; Trombelli L; Lombardo G; Guida L; Cafiero C; Roccuzzo M; Carusi G; Del Fabbro M
    Int J Periodontics Restorative Dent; 2005 Oct; 25(5):461-73. PubMed ID: 16250568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of infrabony defects treated with enamel matrix derivative versus guided tissue regeneration with a nonresorbable membrane.
    Silvestri M; Sartori S; Rasperini G; Ricci G; Rota C; Cattaneo V
    J Clin Periodontol; 2003 May; 30(5):386-93. PubMed ID: 12716329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of treatments of infrabony defects with enamel matrix derivative, guided tissue regeneration with a nonresorbable membrane and Widman modified flap. A pilot study.
    Silvestri M; Ricci G; Rasperini G; Sartori S; Cattaneo V
    J Clin Periodontol; 2000 Aug; 27(8):603-10. PubMed ID: 10959787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects.
    Bokan I; Bill JS; Schlagenhauf U
    J Clin Periodontol; 2006 Dec; 33(12):885-93. PubMed ID: 17092241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regenerative therapy of infrabony defects with or without systemic doxycycline. A randomized placebo-controlled trial.
    Röllke L; Schacher B; Wohlfeil M; Kim TS; Kaltschmitt J; Krieger J; Krigar DM; Reitmeir P; Eickholz P
    J Clin Periodontol; 2012 May; 39(5):448-56. PubMed ID: 22385260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enamel matrix proteins in the treatment of intra-bony defects. A prospective 24-month clinical trial.
    Francetti L; Del Fabbro M; Basso M; Testori T; Weinstein R
    J Clin Periodontol; 2004 Jan; 31(1):52-9. PubMed ID: 15058375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects.
    Heijl L; Heden G; Svärdström G; Ostgren A
    J Clin Periodontol; 1997 Sep; 24(9 Pt 2):705-14. PubMed ID: 9310876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five years clinical results following treatment of human intra-bony defects with an enamel matrix derivative: a randomized controlled trial.
    Bhutda G; Deo V
    Acta Odontol Scand; 2013; 71(3-4):764-70. PubMed ID: 23078573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ready-to-use EMDOGAIN-gel and EMDOGAIN in patients with chronic adult periodontitis.
    Bratthall G; Lindberg P; Havemose-Poulsen A; Holmstrup P; Bay L; Söderholm G; Norderyd O; Andersson B; Rickardsson B; Hallström H; Kullendorff B; Sköld Bell H
    J Clin Periodontol; 2001 Oct; 28(10):923-9. PubMed ID: 11686810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of platelet-rich fibrin vs. enamel matrix derivative in the treatment of periodontal intrabony defects: a clinical and cone beam computed tomography study.
    Gupta SJ; Jhingran R; Gupta V; Bains VK; Madan R; Rizvi I
    J Int Acad Periodontol; 2014 Jul; 16(3):86-96. PubMed ID: 25654961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Emdogain in the treatment of deep intrabony defects: 12-month clinical results. Histologic and radiographic evaluation.
    Parodi R; Liuzzo G; Patrucco P; Brunel G; Santarelli GA; Birardi V; Gasparetto B
    Int J Periodontics Restorative Dent; 2000 Dec; 20(6):584-95. PubMed ID: 11203595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial.
    Zucchelli G; Bernardi F; Montebugnoli L; De SM
    J Periodontol; 2002 Jan; 73(1):3-12. PubMed ID: 11846197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study.
    Wachtel H; Schenk G; Böhm S; Weng D; Zuhr O; Hürzeler MB
    J Clin Periodontol; 2003 Jun; 30(6):496-504. PubMed ID: 12795787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical technique for treatment of infrabony defects with enamel matrix derivative (Emdogain): 3 case reports.
    Rasperini G; Ricci G; Silvestri M
    Int J Periodontics Restorative Dent; 1999 Dec; 19(6):578-87. PubMed ID: 10815596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.